Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of an Investigational Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Participants

NCT04503564 is registered in ClinicalTrials.gov with Capillary Biomedical, Inc. as lead sponsor.

NCT NCT04503564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04503564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of an Investigational Extended Wear Infusion Set for Continuous Subcutaneous Insulin Infusion (CSII) in Type 1 Diabetes Mellitus (T1DM) Participants
Lead sponsor
Capillary Biomedical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 13, 2019
Completion date
November 11, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, insulin-dependent, 1, diabetes mellitus, type 1, type 1 diabetes, type 1 diabetes mellitus